GSK drug meets main goal in late-stage study to treat relentless itch
British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...
Science Daily9h
A new model to explore the epidermal renewal
The mechanisms underlying skin renewal are still poorly understood. Interleukin-38 (IL-38), a protein involved in regulating inflammatory responses, could be a game changer. A team has observed it for ...
The Bolton News on MSN23h
Pharmacist skin condition warning - how to tell a harmless rash from a fatal illness?
A leading pharmacist has warned Brits not to overlook changes to their skin – because they could be vital clues to a ...